Literature DB >> 17135433

Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain.

Vladimir Loparev1, Elisa Martro, Elena Rubtcova, Carlos Rodrigo, Jean-Charles Piette, Eric Caumes, Jean-Paul Vernant, D Scott Schmid, Anne-Marie Fillet.   

Abstract

Thirty-one isolates from France and Spain were genotyped using a published method analyzing DNA sequence variation in open reading frame (ORF) 22, together with an evaluation of three well-characterized single nucleotide polymorphisms (SNP) in ORF 38, 54, and 62. Nineteen were allocated to the European (E) genotype, six were mosaic-1 (M1), and two were mosaic-2 (M2). Four strains were assigned to a new genotype, mosaic-4 (M4). All isolates were wild type, with no Oka vaccine-associated markers. No isolates of the mosaic-3 (M3) or Japanese (J) genotype were observed. We also evaluated 13 selected isolates of E, J, M1, and M2 strains (9 of the 31 described above) using an alternative genotyping method based on the assessment of multiple SNP located in ORF 1, 9, 10, 21, 31, 50, 54, 62, and 68. This method assigns wild-type varicella-zoster virus (VZV) strains to seven genotypes: A1, A2, J1, B1, B2, C, and C1. VZV isolates identified as E (ORF22 method) had the genetic signature of genotype C VZV strains, M1 strains were A1, and M2 were A2. No J strains were detected, but parental Oka and vaccine Oka (genotype J) corresponded to genotype J1. M4 isolates (B) share the SNP array observed for M1 and E viruses, and probably represent recombinants between African-Asian (M1) and European (E) viruses. The two genotyping methods, using entirely different genomic targets, produced identical clusters for the strains examined, suggesting robust phylogenetic linkages among VZV strains circulating in Europe.

Entities:  

Mesh:

Year:  2006        PMID: 17135433      PMCID: PMC1829061          DOI: 10.1128/JCM.01738-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain.

Authors:  K Hawrami; J Breuer
Journal:  J Med Virol       Date:  1997-09       Impact factor: 2.327

2.  XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome.

Authors:  A M Dumas; J L Geelen; M W Weststrate; P Wertheim; J van der Noordaa
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

3.  New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray.

Authors:  Nikolay Sergeev; Elena Rubtcova; Vladimir Chizikov; D Scott Schmid; Vladimir N Loparev
Journal:  J Virol Methods       Date:  2006-05-03       Impact factor: 2.014

Review 4.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

5.  Application of long PCR method of identification of variations in nucleotide sequences among varicella-zoster virus isolates.

Authors:  M Takayama; N Takayama; N Inoue; Y Kameoka
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

6.  Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping.

Authors:  Vladimir N Loparev; Antonio Gonzalez; Marlene Deleon-Carnes; Graham Tipples; Helmut Fickenscher; Einar G Torfason; D Scott Schmid
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Comparative analysis of the restriction endonuclease profiles of the Dumas and Singapore strains of varicella-zoster virus.

Authors:  V T Chow; S S Wan; S Doraisingham; A E Ling
Journal:  J Med Virol       Date:  1993-08       Impact factor: 2.327

8.  Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world.

Authors:  P LaRussa; S Steinberg; A Arvin; D Dwyer; M Burgess; M Menegus; K Rekrut; K Yamanishi; A Gershon
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

9.  Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates.

Authors:  P LaRussa; O Lungu; I Hardy; A Gershon; S P Steinberg; S Silverstein
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003.

Authors:  Michael J Carr; Grace P McCormack; Brendan Crowley
Journal:  J Med Virol       Date:  2004-05       Impact factor: 2.327

View more
  17 in total

1.  Monitoring prevalence of varicella-zoster virus clades in Germany.

Authors:  A Sauerbrei; J Stefanski; A Philipps; A Krumbholz; R Zell; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2010-10-31       Impact factor: 3.402

2.  Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine.

Authors:  Barbara A Pahud; Carol A Glaser; Cornelia L Dekker; Ann M Arvin; D Scott Schmid
Journal:  J Infect Dis       Date:  2010-12-21       Impact factor: 5.226

3.  Simultaneous cocirculation of both European varicella-zoster virus genotypes (E1 and E2) in Mexico city.

Authors:  Araceli Rodríguez-Castillo; Gilberto Vaughan; José Ernesto Ramírez-González; Alejandro Escobar-Gutiérrez
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

4.  Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.

Authors:  Vladimir N Loparev; Elena N Rubtcova; Vanda Bostik; Dhwani Govil; Christopher J Birch; Julian D Druce; D Scott Schmid; Margaret C Croxson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

5.  Novel approach for genotyping varicella-zoster virus strains from Germany.

Authors:  Jonas Schmidt-Chanasit; Martin Stürmer; Anke Hahn; Susanne G Schäd; Gerd Gross; Rainer G Ulrich; Gerald Heckel; Hans Wilhelm Doerr
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

6.  Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts.

Authors:  Randall J Cohrs; Satish K Mehta; D Scott Schmid; Donald H Gilden; Duane L Pierson
Journal:  J Med Virol       Date:  2008-06       Impact factor: 2.327

Review 7.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

8.  Coinfection with two closely related alphaherpesviruses results in a highly diversified recombination mosaic displaying negative genetic interference.

Authors:  Benoît Muylkens; Frédéric Farnir; François Meurens; Frédéric Schynts; Alain Vanderplasschen; Michel Georges; Etienne Thiry
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

9.  Genotyping of clinical varicella-zoster virus isolates collected in China.

Authors:  Jingjing Liu; Mingli Wang; Lin Gan; Sen Yang; Jason Chen
Journal:  J Clin Microbiol       Date:  2009-02-25       Impact factor: 5.948

Review 10.  A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008.

Authors:  Judith Breuer; Charles Grose; Peter Norberg; Graham Tipples; D Scott Schmid
Journal:  J Gen Virol       Date:  2010-01-13       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.